PD-1 expression and its correlation with tumour infiltrating lymphocytes and Ki67 in patients with breast cancer

被引：0
|
作者：
Vos, Hanne
Lambein, Kathleen
Floris, Giuseppe
Nevelsteen, Ines
Smeets, Ann
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
[2] Katholieke Univ Leuven, Translat Cell & Tissue Res, Leuven, Belgium
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-05-15
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Ki67 proliferative index in patients with early breast cancer and its association with clinicopathological factors
    Damjanovic, D.
    Rajc, J.
    Marinovic, E. Matuzalem
    Dumencic, B.
    Gudelj, R.
    Bakula, M.
    Alaghehbandan, R.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S67 - S67
  • [42] PROGNOSTIC FACTOR KI67 FOR BREAST CANCER PATIENTS IN EACH SUBGROUP
    Niikura, N.
    Masuda, S.
    Terada, M.
    Terao, M.
    Kumaki, N.
    Oshitanai, R.
    Morioka, T.
    Tsuda, B.
    Okamura, T.
    Saito, Y.
    Suzuki, Y.
    Tokuda, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 127 - 127
  • [43] Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors
    de Gregorio, Amelie
    Friedl, Thomas Wolfram Paul
    Hering, Eva
    Widschwendter, Peter
    de Gregorio, Nikolaus
    Bekes, Inga
    Janni, Wolfgang
    Dayan, Davut
    Huober, Jens Bodo
    ONCOLOGY, 2021, 99 (12) : 780 - 789
  • [44] PD-1/PD-L1 expression in uveal melanoma: Prognostic significance with tumour-infiltrating lymphocytes and clinicopathological parameters
    Singh, L.
    Singh, M. K.
    Rizvi, M. A.
    Kashyap, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1422 - S1422
  • [45] PDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to Chemotherapy
    Mathur, Sandeep
    Johnson, Anjana
    Deo, S. V. S.
    Gogia, Ajay
    Kahol, Shruti
    Jain, Deepali
    Iyer, Venkateswaran
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 208 - 209
  • [46] PDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to Chemotherapy
    Mathur, Sandeep
    Johnson, Anjana
    Deo, S. V. S.
    Gogia, Ajay
    Kahol, Shruti
    Jain, Deepali
    Iyer, Venkateswaran
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 208 - 209
  • [47] Changes in Ki67 expression in breast cancer during the menstrual cycle and menopause
    Fujita, Takashi
    Sawaki, Masataka
    Hattori, Masaya
    Kondo, Naoto
    Yoshimura, Akiyo
    Ichikawa, Mari
    Adachi, Yayoi
    Hisada, Tomoka
    Kotani, Haruru
    Ishigro, Junko
    Iwata, Hiroji
    CANCER RESEARCH, 2015, 75
  • [48] Local immunologic environment related with tumor infiltrating lymphocytes (TIL) and PD-1/PD-L1 expression in early stage breast cancer
    Okabe, M.
    Toh, U.
    Iwakuma, N.
    Mishima, M.
    Kawahara, A.
    Kage, M.
    Itoh, K.
    Akagi, Y.
    CANCER RESEARCH, 2016, 76
  • [49] PROGNOSTIC SIGNIFICANCE OF KI67 PROTEIN EXPRESSION IN METASTATIC BREAST CANCER SURVIVAL
    Todorovic-Rakovic, Natasa
    Kanjer, Ksenija
    Neskovic-Konstantinovic, Zora
    BREAST, 2015, 24 : S73 - S73
  • [50] Immunohistochemical expression of PDL1 and Ki67 in glioma and its correlation with treatment and overall survival
    Kumar, Vineet
    Raghuvanshi, Shivanjali
    Bhalla, Shalini
    Rawat, Shalini
    Ojha, Bal Krishna
    Srivastava, Chhitij
    Goel, Madhu Mati
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2025, 21 (01) : 145 - 150
12345